DNB//BACK BAY Healthcare CEO Forum

 
 

MAY 7, 2024 | WEBINAR

DNB//Back Bay CEO Roundtable Discussion: “Alternative Financing in Today’s Healthcare Market”

  • Ann Grabe, Global Head of Healthcare Banking at DNB

  • Jonathan Gertler, CEO and Managing Partner at Back Bay Life Science Advisors

  • Patrik Ling, Senior Research Analyst at DNB

  • Clarke Futch, Chairman & CEO of HealthCare Royalty Partners

  • Chris Posner, CEO of Cara Therapeutics

One of the critical issues that all companies face is, of course, that markets are unpredictable. Diversified financing strategies are critical in enabling corporate success.

In this CEO Roundtable Discussion, “Alternative Financing in Today’s Healthcare Market,” the DNB//Back Bay Healthcare Partnership invites Clarke Futch and Chris Posner to share more about the why, when, and how of royalty financing and what this experience looked like for Cara Therapeutics. 

Topics include: 

  • The state of the healthcare markets in the US and Europe

  • The history and current strategy/targets for HCRx

  • The rationale and drivers for taking a royalty approach

  • Case study example of HCRx and Cara Therapeutics

  • Process perspectives and lessons learned 

Meet our healthcare team: www.bblsa.com/dnb-back-bay-healthcare-team

Watch the video above for the discussion.

Jocelyn Miller